...
首页> 外文期刊>Chemistry central journal >Design, synthesis and evaluation of anticancer activity of novel 2-thioxoimidazolidin-4-one derivatives bearing pyrazole, triazole and benzoxazole moieties
【24h】

Design, synthesis and evaluation of anticancer activity of novel 2-thioxoimidazolidin-4-one derivatives bearing pyrazole, triazole and benzoxazole moieties

机译:新型带有吡唑,三唑和苯并恶唑部分的2-thioxoimidazolidin-4-one衍生物的设计,合成和抗癌活性评估

获取原文
           

摘要

A novel series of substituted 2?thiohydantoin incorporated with benzoimidazole, pyrazole, triazole and/or benzoxa?zole moieties has been synthesized using (E)?3?[1?(4?bromophenyl)ethylideneamino]?2?thioxoimidazolidin?4?one 1as the key starting material. The key material 1 also, reacted with an acetic anhydride, aromatic aldehydes, secondaryamines, formaldehyde and triethyl orthoformate to give the corresponding acetyl, chalcone, Mannich bases and eth?oxymethylene derivatives, respectively. The structures of the novel compounds were confrmed by spectral data andelemental analysis. The cytotoxic activity of all synthesized compounds was assessed in vitro against human hepato?cellular cancer cell line (HePG?2) and breast carcinoma cell line (MCF?7). The bioassay results revealed that compound14 has the best activity against HePG?2 cell line (IC50= 2.33 μg/mL), while compound 5 has the best activity againstMCF?7 cell line (IC50= 3.98 μg/mL).
机译:(E)′3′[1′(4′溴苯基)亚乙基氨基]′2′硫代氧杂咪唑烷酮′4′′合成了一系列新的取代的2′硫代乙内酰脲与苯并咪唑,吡唑,三唑和/或苯并恶唑基部分结合。 1作为关键的起始材料。关键材料1也与乙酸酐,芳族醛,仲胺,甲醛和原甲酸三乙酯反应,分别得到相应的乙酰基,查尔酮,曼尼希碱和乙氧基亚甲基衍生物。通过光谱数据和元素分析证实了该新型化合物的结构。在体外评估了所有合成化合物对人肝细胞癌细胞系(HePG?2)和乳腺癌细胞系(MCF?7)的细胞毒活性。生物测定结果表明,化合物14对HePG?2细胞系具有最佳活性(IC50 = 2.33μg/ mL),而化合物5对MCF?7细胞系具有最佳活性(IC50 = 3.98μg/ mL)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号